risperidone

Risperidone (R 64 766) is a selective blocker of dopamine D2 receptors and serotonin 5-HT2 receptors that act as an atypical antipsychotic agent.

Risperidone Mesylate is a selective serotonin 5-HT2 receptor and dopamine D2 receptor blocker.

Risperidone-d4 is a deuterated form of risperidone. Risperidone blocks 5-HT₂ receptors, inhibits P-glycoprotein, and antagonizes dopamine D₂ receptors (Ki 4.8 / 5.9 nM for 5-HT₂A / D₂), showing potential in research related to neuroscience.

Risperidone hydrochloride (R 64 766 hydrochloride) is a 5-HT2 receptor blocker, P-glycoprotein inhibitor, and dopamine D2 receptor antagonist, with activity on 5-HT2A (Ki: 4.8 nM) and dopamine D2 (Ki: 5.9 nM) receptors.

Risperidone E-oxime is an impurity of Risperidone, a serotonin 5-HT2 receptor blocker, P-glycoprotein inhibitor, and potent dopamine D2 receptor antagonist (Kis of 4.8 and 5.9 nM for 5-HT2A and dopamine D2 receptors, respectively).

Risperidone-d6 (R 64 766-d6) is the deuterated form of Risperidone. Risperidone functions as a blocker of the 5-HT2 receptor, an inhibitor of P-glycoprotein (P-Glycoprotein), and an antagonist of the dopamine D2 receptor, with Ki values of 4.8 nM and 5.9 nM for the 5-HT2A and dopamine D2 receptors, respectively.

Risperidone (Standard) is a reference standard for research and analysis in studies involving Risperidone. Risperidone (R 64 766) is a selective blocker of dopamine D2 receptors and serotonin 5-HT2 receptors that act as an atypical antipsychotic agent.

7-Hydroxyrisperidone (7-RispOH) is a metabolite of Risperidone. Risperidone acts as a 5-HT2 receptor blocker, an inhibitor of P-glycoprotein (P-Glycoprotein), and an antagonist of the dopamine D2 receptor.

Paliperidone (9-hydroxyrisperidone)(Invega) is used as an atypical antipsychotic. It applies to the acute and maintenance treatment of schizophrenia. Chemically, paliperidone is the primary active metabolite of the older atypical antipsychotic risperidone.

Setmelanotide (RM-493) is a selective melanocortin-4 receptor agonist with EC50 values of 0.27 and 0.28 nM for human and rat MC4R. Setmelanotide enhances cAMP signaling, demonstrates functional selectivity, activates sympathetic preganglionic neurons to influence blood pressure, and is widely used to probe MC4R-MRAP2 interactions. Setmelanotide contributes to obesity-related research by modulating hunger and satiety circuits, reversing risperidone-induced weight gain in mice, and helping characterize MC4R variants in pediatric metabolic disorders. The anti-inflammatory actions of Setmelanotide in astrocytoma cells and the utility in combination with calorie restriction further highlight its broad value in metabolic and neuroendocrine research.

Paliperidone-d4 is a deuterated compound of Paliperidone. Paliperidone has a CAS number of 144598-75-4. Paliperidone(Invega) is used as an atypical antipsychotic. It applies to the acute and maintenance treatment of schizophrenia. Chemically, paliperidone is the primary active metabolite of the older atypical antipsychotic risperidone.

Paliperidone (Standard) is a reference standard for research and analysis in studies involving Paliperidone. Paliperidone (9-hydroxyrisperidone)(Invega) is used as an atypical antipsychotic. It applies to the acute and maintenance treatment of schizophrenia. Chemically, paliperidone is the primary active metabolite of the older atypical antipsychotic risperidone.